CCI-779 in Treating Patients With Metastatic Melanoma

NCT00022464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: temsirolimus

Sponsor

City of Hope Medical Center

Collaborators

[object Object]